MTOR and breast cancer: Moreover, other studies suggest that type XVII collagen could have a chemotactic role when interacting with αIIb integrin in the tumor front and interestingly, in breast cancer cells type XVII collagen seems to suppress tumor growth by reducing the expression of Ki67 and deactivating the mTOR signaling pathway [33, 34].